Search clinical trials for: oculocutaneous albinism (OCA)
Total 126 results
-
Merz North America, Inc.CompletedVolume Loss in the Infraorbital Hollow AreaUnited States, Puerto Rico
-
Merz North America, Inc.CompletedCorrection of Volume Loss in the Infraorbital Hollow AreaUnited States
-
Intercept PharmaceuticalsTerminatedBiliary AtresiaIsrael, United Kingdom, Poland, Belgium, France, Germany, Italy, Netherlands, Spain
-
Medical University of GrazNational Bank of AustriaCompleted
-
Intercept PharmaceuticalsCompletedHealthyUnited States
-
Intercept PharmaceuticalsNot yet recruiting
-
Nanjing Chia-tai Tianqing PharmaceuticalRecruitingPrimary Biliary CholangitisChina
-
Naga P. ChalasaniNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Intercept PharmaceuticalsTerminatedAlcoholic HepatitisUnited States
-
Intercept PharmaceuticalsCompleted
-
Hospital y Clinica OCA, S.A. de C.V.Unknown
-
Baxter Healthcare CorporationRecruitingAcute Kidney Failure | Chronic Kidney FailureChina
-
Cedars-Sinai Medical CenterHarvard Medical School (HMS and HSDM); National Institute of Diabetes and Digestive... and other collaboratorsWithdrawn
-
Hospital DonostiaUnknownHelicobacter Pylori InfectionSpain
-
Intercept PharmaceuticalsCompletedPrimary Sclerosing Cholangitis (PSC)United States, Italy
-
Maastricht University Medical CenterZorgverzekeraar CZ; Rotterdam University of Applied Sciences; Zorgverzekeraar... and other collaboratorsRecruitingMusculoskeletal PainNetherlands
-
Johns Hopkins UniversityClark Charitable Foundation Inc.CompletedOcular Albinism (OA) | Oculocutaneous Albinism (OCA)United States
-
Prehospital Center, Region ZealandCompletedOut-Of-Hospital Cardiac Arrest
-
Methodist Health SystemEnrolling by invitation
-
Fundación de Investigación Biomédica - Hospital...CompletedBacterial Infection Due to Helicobacter Pylori (H. Pylori)Spain
-
University of AlbertaRevive Wellness Inc.Recruiting
-
Intercept PharmaceuticalsActive, not recruitingPrimary Biliary CholangitisNetherlands, United Kingdom, Korea, Republic of, Germany, Australia, Estonia, Belgium, France, Czechia, Croatia, Greece, Hungary, Israel, Lithuania, Norway, Poland, Spain
-
Jan Medical, Inc.Terminated
-
Intercept PharmaceuticalsTerminatedLiver Cirrhosis, BiliaryUnited States, Spain, Korea, Republic of, Australia, Finland, Israel, Lithuania, United Kingdom, Belgium, Netherlands, Estonia, Brazil, Italy, Serbia, Sweden, Argentina, Austria, Canada, Chile, Denmark, France, Germany, Hong Kong, Hun... and more
-
Intercept PharmaceuticalsTerminatedLiver Cirrhosis, BiliaryUnited States, Argentina, Spain, Belgium, Germany, Canada, Australia, Estonia, Brazil, Hungary, Italy, Lithuania
-
University of HohenheimUniversidad de Costa RicaCompletedBiological AvailabilityCosta Rica, Germany
-
FluGen IncAccelovanceCompleted
-
Suthat LiangpunsakulNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Intercept PharmaceuticalsCompletedAlcohol ConsumptionUnited States
-
Lithuanian University of Health SciencesCompleted
-
AlloSourceNot yet recruiting
-
Intercept PharmaceuticalsCompletedLiver Cirrhosis, BiliaryUnited States, France, Germany, Spain, United Kingdom, Canada, Austria
-
Olympus Corporation of the AmericasUniversity of Florida; Rhode Island Hospital; University of Massachusetts, Worcester and other collaboratorsSuspendedSmall Bowel DiseaseUnited States
-
Intercept PharmaceuticalsCompletedNonalcoholic SteatohepatitisUnited States
-
Intercept PharmaceuticalsCompletedNonalcoholic Steatohepatitis | Compensated CirrhosisUnited States, Spain, France, Australia, New Zealand, Puerto Rico, Germany, Canada, United Kingdom, Hungary, Poland, Ukraine
-
Intercept PharmaceuticalsCompletedPrimary Biliary CirrhosisUnited States, Spain, United Kingdom, Austria, Netherlands, Australia, Italy, Germany, Poland, Sweden, France, Canada, Belgium
-
FluGen IncAccelovanceCompleted
-
Clínica Los YosesNovo Nordisk A/SCompletedDiabetes Mellitus, Type 2Costa Rica, El Salvador, Guatemala, Honduras
-
Chinese PLA General HospitalCompleted
-
National Institute of Diabetes and Digestive and...CompletedNonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD)United States
-
Intercept PharmaceuticalsTerminatedLiver Cirrhosis, BiliaryUnited States, Spain, Canada, United Kingdom, France, Germany, Austria, Netherlands
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingPrimary Biliary CirrhosisChina
-
Intercept PharmaceuticalsActive, not recruitingPrimary Biliary CholangitisUnited States
-
Intercept PharmaceuticalsSyneos Health; Global PBC Study Group; Target RWE; UK PBC GroupCompletedPrimary Biliary CholangitisUnited States
-
PfizerCompletedDistal, Subungual OnychomycosisMexico
-
PfizerCompleted
-
Intercept PharmaceuticalsSyneos Health; Global PBC Study Group; Target RWE; UK PBC Study GroupWithdrawnPrimary Biliary CholangitisUnited States
-
Intercept PharmaceuticalsCompletedPrimary Biliary CirrhosisUnited States
-
Boston Scientific CorporationCompletedParoxysmal Atrial Fibrillation (PAF)United States, Spain, Germany, Australia, United Kingdom, Sweden, Czechia, France, Portugal
-
PfizerActive, not recruiting
-
Dow Pharmaceutical SciencesCompleted